Retractable Technologies, Inc. (RVP)
NYSEAMERICAN: RVP · Real-Time Price · USD
0.846
+0.016 (1.93%)
At close: Feb 21, 2025, 4:00 PM
0.840
-0.006 (-0.71%)
After-hours: Feb 21, 2025, 7:37 PM EST
Retractable Technologies Market Cap
Retractable Technologies has a market cap or net worth of $25.33 million as of February 21, 2025. Its market cap has decreased by -28.86% in one year.
Market Cap
25.33M
Enterprise Value
-10.06M
1-Year Change
-28.86%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since May 4, 2001, Retractable Technologies's market cap has decreased from $246.90M to $25.33M, a decrease of -89.74%. That is a compound annual growth rate of -9.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 25.30M | 22.82% |
| Dec 31, 2024 | 20.60M | -37.95% |
| Dec 29, 2023 | 33.20M | -38.52% |
| Dec 30, 2022 | 54.00M | -76.92% |
| Dec 31, 2021 | 234.00M | -35.57% |
| Dec 31, 2020 | 363.20M | 641.22% |
| Dec 31, 2019 | 49.00M | 152.58% |
| Dec 31, 2018 | 19.40M | -12.61% |
| Dec 29, 2017 | 22.20M | -19.57% |
| Dec 30, 2016 | 27.60M | -68.09% |
| Dec 31, 2015 | 86.50M | -37.05% |
| Dec 31, 2014 | 137.40M | 65.34% |
| Dec 31, 2013 | 83.10M | 250.63% |
| Dec 31, 2012 | 23.70M | -20.47% |
| Dec 30, 2011 | 29.80M | -28.88% |
| Dec 31, 2010 | 41.90M | 7.16% |
| Dec 31, 2009 | 39.10M | 93.56% |
| Dec 31, 2008 | 20.20M | -44.04% |
| Dec 31, 2007 | 36.10M | -47.14% |
| Dec 29, 2006 | 68.30M | -18.98% |
| Dec 30, 2005 | 84.30M | -20.99% |
| Dec 31, 2004 | 106.70M | -17.80% |
| Dec 31, 2003 | 129.80M | 68.13% |
| Dec 31, 2002 | 77.20M | -28.58% |
| Dec 31, 2001 | 108.10M | -56.22% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |